Immunomedics Inc. buy melinda
Start price
10.11.17
/
50%
€11.50
Target price
20.12.17
€13.95
Performance (%)
21.39%
End price
20.12.17
€13.96
Summary
This prediction ended on 20.12.17 with a price of €13.96. The prediction had a final performance of 21.39%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immunomedics Inc. | - | - | - | - |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% | 60.422% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% | 87.823% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% | 66.929% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% | 60.457% |
Comments by melinda for this prediction
In the thread Immunomedics Inc. diskutieren
Immunomedics, Inc. ist eine klinische Phase-biopharmazeutisches company.It im Geschäft der Erforschung, Entwicklung, Herstellung und Vermarktung von biopharmazeutischen products.The Unternehmen in erster Linie auf die Entwicklung von monoklonalen, Antikörper-basierte Produkte für die Behandlung o Gezielte
Stopped prediction by melinda for Immunomedics Inc.
Immunomedics Inc.
Start price
Target price
Perf. (%)
€17.42
31.03.19
31.03.19
€22.55
04.11.21
04.11.21
326.29%
05.11.21
05.11.21
Immunomedics Inc.
Start price
Target price
Perf. (%)
€10.37
10.11.17
10.11.17
€12.58
20.12.17
20.12.17
21.39%
20.12.17
20.12.17